Rhythm Formulations Private Limited

Rhythm Formulations Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U51397TG2009PTC063507 Incorporated 30 April 2009 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹97.06 Lakh
▼ 25% YoY
Net loss · FY 2025
₹5.97 Lakh
Net margin -6.1%
EBITDA · FY 2025
-₹5.4 Lakh
EBITDA margin -5.6%
Authorised capital
₹90 Lakh
Registered with MCA
Paid-up capital
₹70 Lakh
Issued & subscribed
Company age
17 yrs
Est. 2009
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered

About Rhythm Formulations Private Limited

Data last updated:

Rhythm Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 April 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51397TG2009PTC063507. Its GSTIN is 33AAECR3565J1Z9 (Tamil Nadu).

The company has an authorised share capital of ₹90 Lakh and a paid-up capital of ₹70 Lakh. It is led by directors including Raghuraman Parthasarathy (Managing Director) and Raghuraman Indhira.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 402 Padmaja Courts – 1 Plot No:73 Srinagar Colony, Hyderabad, Telangana, India – 500073.

As per the financials filed for FY 2025, the company reported a revenue of ₹97.06 Lakh, a decline of 25% compared to the previous year. For the same year it recorded a net loss of ₹5.97 Lakh (net margin -6.1%) and EBITDA of -₹5.4 Lakh (EBITDA margin -5.6%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51397TG2009PTC063507
Registration Number 063507
Incorporation Date 30 April 2009
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Rhythm Formulations has one previous CIN (Corporate Identification Number): U51397AP2009PTC063507. The current CIN is U51397TG2009PTC063507, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51397TG2009PTC063507Current
U51397AP2009PTC063507Previous

Contact details

Rhythm Formulations Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    402 Padmaja Courts – 1 Plot No:73 Srinagar Colony, Hyderabad, Telangana, India – 500073
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Rhythm Formulations Private Limited, buy the company report.

Comprehensive company report
Rhythm Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Rhythm Formulations is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Rhythm Formulations Private Limited, buy the company report.

Financials of Rhythm Formulations Private Limited

FY 2025 filings available

Rhythm Formulations Private Limited reported revenue of ₹97.06 Lakh (down 25% YoY) for FY 2025.

Revenue · FY 2025
₹97.06 Lakh ▼ 25%
Net loss · FY 2025
₹5.97 Lakh margin -6.1%
EBITDA · FY 2025
-₹5.4 Lakh margin -5.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 25%
3 years · compounded
▼ 3%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 154%
3 years · compounded
▼ 41%
5 years · compounded
▲ 23%

Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 25% fall in the latest year. EBITDA fell 154% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹5.4 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹5.97 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-5.6%
Net Profit Margin-6.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rhythm Formulations Private Limited, buy the company report.

Board of directors of Rhythm Formulations Private Limited

Rhythm Formulations has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Raghuraman ParthasarathyManaging Director02 May 20242 Years 5 MonthsCurrent
Raghuraman IndhiraDirector02 May 20242 Years 5 MonthsCurrent
Madhavan DevarajDirector18 Apr 20242 Years 6 MonthsCurrent
Archana RaguramanDirector18 Apr 20242 Years 6 MonthsCurrent

Auditor

Rhythm Formulations Private Limited is audited by A RAMACHANDRAN & ASSOCIATES for the financial year 2021.

Auditor firmFinancial yearFirm registration number
A RAMACHANDRAN & ASSOCIATESFY 2021012231S

Shareholding

The shareholding of Rhythm Formulations Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Rhythm Formulations Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rhythm Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Rhythm Formulations has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAECR3565J1Z9Tamil NaduActive01 Jul 2017

To see the full GST registrations and return filing status of Rhythm Formulations Private Limited, buy the company report.

Recent activity

Rhythm Formulations Private Limited has 11 board changes on record since 2010: 4 appointments and 7 cessations. The latest: Raghuraman Indhira was appointed as Director on 02 May 2024.

AGM
Rhythm Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rhythm Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Raghuraman Indhira was appointed as Director.
Appointed
Raghuraman Parthasarathy was appointed as Managing Director.
Ceased
Chithiraipoo Venkatesan ceased to be Director.
Appointed
Archana Raguraman was appointed as Director.
Appointed
Madhavan Devaraj was appointed as Director.
Ceased
Karthick Raguraman ceased to be Additional Director.
Ceased
Raghuraman Indhira ceased to be Director.
Ceased
Neelamohan ceased to be Additional Director.
Ceased
Raghuraman Parthasarathy ceased to be Managing Director.
Ceased
Satishkumar Murugesan ceased to be Director.

2 earlier events are in the company report.

Frequently asked questions

Rhythm Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 April 2009 (17+ years old) and is registered under CIN U51397TG2009PTC063507.

Rhythm Formulations has 4 current directors:

The latest financial statements of Rhythm Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Rhythm Formulations is 33AAECR3565J1Z9, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Rhythm Formulations is U51397TG2009PTC063507. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rhythm Formulations was incorporated on 30 April 2009, making it 17+ years old. It is registered with the Registrar of Companies, Hyderabad.

Raghuraman Indhira was appointed as Director on 02 May 2024. Raghuraman Parthasarathy was appointed as Managing Director on 02 May 2024. Chithiraipoo Venkatesan ceased to be Director on 26 Apr 2024. Rhythm Formulations has 11 board changes on record in total.

The registered office of Rhythm Formulations is at 402 Padmaja Courts – 1 Plot No:73 Srinagar Colony, Hyderabad, Telangana, India – 500073.

Rhythm Formulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Rhythm Formulations is compliant as of 23 July 2026. The company is actively filing with the Registrar of Companies.